首页> 外文期刊>Plastic and reconstructive surgery >Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications.
【24h】

Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications.

机译:使用脱细胞真皮基质进行基于植入物的乳房再造以及术后并发症的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Acellular dermal matrix has been popularized as an adjunct to tissue expander or implant breast reconstruction given its utility in providing additional coverage and support for the inferior pole. This study was performed to assess the risk of postoperative complications associated with the use of acellular dermal matrix-assisted implant-based reconstruction. METHODS: The authors performed a retrospective analysis of consecutive immediate breast reconstructions performed over a 6-year period. A total of 415 implant-based reconstructions were divided into two groups: tissue expander or implant-based reconstruction with or without acellular dermal matrix. Demographic information, comorbidities, oncologic data, adjuvant therapy, and complications were collected for comparison. RESULTS: A total of 283 patients underwent 415 immediate breast reconstructions (151 unilateral and 132 bilateral); 269 reconstructions were performed using tissue expander or implants with acellular dermal matrix, and 146 reconstructions were performed without acellular dermal matrix. The seroma and infection rates were higher in the acellular dermal matrix group (14.1 versus 2.7 percent, p = 0.0003, for seroma; 8.9 versus 2.1 percent, p = 0.0328, for infection). Multiple logistic regression analysis showed that acellular dermal matrix and body mass index were statistically significant risk factors for developing seroma and infection. The use of acellular dermal matrix increased the odds of seroma by 4.24 times (p = 0.018) and infection by 5.37 times (p = 0.006). CONCLUSIONS: Acellular dermal matrix has enhanced implant-based reconstruction and remains useful in immediate prosthetic breast reconstruction. It is associated, however, with higher rates of postoperative seroma and infection. Careful patient selection, choice of tissue expander/implant volume, and postoperative management are warranted to optimize overall reconstructive outcome.
机译:背景:无细胞真皮基质已被广泛用作组织扩张器或植入物乳房重建的辅助手段,因为它可为下极提供额外的覆盖和支撑。进行这项研究是为了评估与使用脱细胞真皮基质辅助种植体重建术相关的术后并发症风险。方法:作者对6年内连续进行的立即乳房再造进行了回顾性分析。总共415个基于植入物的重建物分为两组:组织扩张器或有或没有脱细胞真皮基质的基于植入物的重建物。收集人口统计学信息,合并症,肿瘤学数据,辅助治疗和并发症进行比较。结果:总共283例患者接受了415例即刻乳房再造(151例单侧和132例双侧)。使用具有无细胞真皮基质的组织扩张器或植入物进行269例重建,无细胞真皮基质进行146例重建。在无细胞真皮基质组中,血清肿和感染率更高(血清肿,分别为14.1%和2.7%,p = 0.0003;感染的分别为8.9%和2.1%,p = 0.0328)。多元逻辑回归分析表明,脱细胞真皮基质和体重指数是发生血清肿和感染的统计学显着危险因素。使用脱细胞真皮基质可将血清肿的几率提高4.24倍(p = 0.018),将感染的几率提高5.37倍(p = 0.006)。结论:脱细胞真皮基质增强了基于植入物的重建,并在即时义乳修复中仍然有用。但是,它与术后血清肿和感染的发生率较高有关。必须仔细选择患者,选择组织扩张器/植入物的体积以及术后管理,以优化总体重建结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号